Targeting NF-κB p105 (Ser932): Precise Regulation of the NF-κB Signaling Pathway

Targeting NF-κB p105 (Ser932): Precise Regulation of the NF-κB Signaling Pathway

 

1. Concept

Nuclear factor-κB (NF-κB) is a highly conserved transcriptional regulatory network in eukaryotes, central to immune responses, inflammation, cell survival, and proliferation. The mammalian NF-κB family includes five members, with NF-κB1 consisting of the precursor protein p105 and its mature product p50. Phosphorylation at serine 932 (Ser932) of p105 is a critical post-translational modification (PTM) that regulates the NF-κB signaling pathway. This modification influences p105 processing into p50, modulates the stability and activity of NF-κB complexes (e.g., p50/p65 heterodimers), and fine-tunes downstream gene expression. As a key regulatory node, p105 (Ser932) phosphorylation enables cells to precisely respond to extracellular stimuli, making it a focal point for signal transduction research and therapeutic development.

2. Research Frontiers

Recent advances have highlighted the significance of p105 (Ser932) phosphorylation in NF-κB pathway regulation. While p65 (RelA) has long been recognized as the primary transcriptional activator of NF-κB, emerging studies show that p105 (Ser932) phosphorylation plays a complementary role in pathway modulation. This modification is catalyzed by specific kinases (e.g., IKK complexes) in response to stimuli such as TNF-α, IL-1β, and LPS. It regulates p105’s proteasomal processing into p50, thereby controlling the availability of functional NF-κB dimers.

Cutting-edge research uses phospho-specific antibodies to dissect the crosstalk between p105 (Ser932) phosphorylation and other PTMs (e.g., p65 Ser536 phosphorylation, acetylation). Studies link aberrant Ser932 phosphorylation to diseases driven by NF-κB dysregulation, including cancer, autoimmune disorders, and chronic inflammation. Future directions focus on identifying upstream kinases and phosphatases that regulate Ser932 phosphorylation, and developing small-molecule modulators to target this site for precise pathway intervention.

3. Research Significance

p105 (Ser932) research holds profound significance for understanding NF-κB pathway dynamics and disease mechanisms. The NF-κB pathway’s ability to mount context-specific responses relies on precise PTM-based regulation, and Ser932 phosphorylation is a key component of this "modification code." By controlling p105 processing, Ser932 phosphorylation balances the pool of inhibitory p105 and active p50, preventing excessive or insufficient pathway activation.

Dysregulation of Ser932 phosphorylation contributes to pathological processes: increased phosphorylation may drive chronic inflammation or tumor cell proliferation, while decreased phosphorylation may impair immune responses. Understanding this modification provides insights into disease-specific NF-κB activation patterns, offering new biomarkers and therapeutic targets. Additionally, Ser932 phosphorylation serves as a pharmacodynamic marker for evaluating NF-κB-targeted therapies, bridging basic research and clinical translation.

4. Related Mechanisms, Research Methods, and Product Applications

Mechanisms

p105 (Ser932) phosphorylation regulates the NF-κB pathway through core mechanisms:

  • p105 Processing Control: Phosphorylation at Ser932 triggers p105’s proteasomal processing, generating mature p50. This increases the availability of p50 for dimerization with p65 or other NF-κB subunits, enhancing pathway activation.
  • Complex Stability Modulation: Ser932 phosphorylation influences p105’s interaction with IκB proteins and other regulatory factors, affecting the stability and subcellular localization of NF-κB complexes.
  • Signal Integration: This modification integrates upstream stimuli (e.g., pro-inflammatory cytokines, stress signals) to fine-tune downstream gene expression, ensuring appropriate biological responses.

Research Methods and Product Applications

ANT BIO PTE. LTD.’s high-quality phospho-specific antibody (under the Starter sub-brand) is an indispensable tool for studying p105 (Ser932) regulation:

Product: Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb (S0B1284)

    • Pathway Activation Analysis: Detects Ser932-phosphorylated p105 via Western Blot (WB) or immunofluorescence (IF), enabling quantification of p105 processing and NF-κB pathway activation under different stimuli.
    • Mechanistic Dissection: Helps identify upstream kinases (e.g., IKK) and phosphatases regulating Ser932 phosphorylation, elucidating the molecular network controlling p105 function.
    • Disease Research: Analyzes aberrant Ser932 phosphorylation in disease models or clinical samples, uncovering its role in cancer, inflammation, or autoimmune disorders.
    • Therapeutic Evaluation: Serves as a pharmacodynamic marker for NF-κB-targeted drugs, monitoring changes in Ser932 phosphorylation to validate target engagement and pathway inhibition.

5. Brand Mission

ANT BIO PTE. LTD. is dedicated to empowering the global life science community with innovative, high-quality reagents and solutions to accelerate scientific discovery and improve human health. We specialize in providing antibodies, recombinant proteins, ELISA kits, and general life science reagents through three dedicated sub-brands: Absin (general reagents and kits), Starter (antibodies), and UA (recombinant proteins). Backed by advanced development platforms—including recombinant monoclonal antibody platforms, multi-system recombinant protein expression (E.coli, CHO, HEK293, Insect Cells), One-Step ELISA Platform, and PTM Pan-Modification Antibody Platform—we adhere to stringent international certifications (EU 98/79/EC, ISO9001, ISO13485). Our mission is to be a trusted partner for researchers worldwide, delivering reliable products and tailored services that drive breakthroughs in signal transduction, immunology, and disease therapeutics.

6. Related Product List

Product Catalog Number

Product Name

Host

S0B1284

Phospho-NF-κB p105 (Ser932) Recombinant Rabbit mAb (S-1146-117)

Rabbit

7. AI Disclaimer

This article is AI-compiled and interpreted based on the original work. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

 

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.